Androgen receptor protein is down-regulated by basic fibroblast growth factor in prostate cancer cells

British Journal of Cancer

Volumn 82, Issue 1, 2000, Pages 39-45

  Cronauer, M V ^a,b   Nessler Menardi, C ^a   Klocker, H ^a   Maly, K ^a   Hobisch, A ^a   Bartsch, G ^a   Culig, Z ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Androgen receptor; Basic fibroblast growth factor; Calcium influx; Prostate cancer

Indexed keywords

ANDROGEN RECEPTOR; ANDROSTANOLONE; BASIC FIBROBLAST GROWTH FACTOR; CALCIMYCIN; CALCIUM ION; MESSENGER RNA; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CANCER CELL CULTURE; CONTROLLED STUDY; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LIGAND BINDING; PRIORITY JOURNAL; PROSTATE CANCER; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0033988195     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.1999.0874     Document Type: Article

References (46)

1. Baird A and Böhlen P (1991) Fibroblast growth factors. In: Peptide Growth Factors and Their Receptors I, Sporn MB and Roberts AB (eds). pp. 369-418. Springer: Heidelberg
2. Bikfalvi A (1995) Significance of angiogenesis in tumour progression and metastasis. Eur J Cancer 31A: 1101-1104
3. Bradford M (1978) A rapid and sensitive method for the quantitation of microgram quantities of protein using the principle of protein-dye binding. Anal Biochem 72: 248-254
4. Chaproniere DM and McKeehan WL (1986) Serial culture of single adult human prostalic epithelial cells in serum-free medium containing low calcium and a new growth factor from bovine brain. Cancer Res 46: 819-824
5. Cheng B, McMahon DG and Mattson MP (1993) Modulation of calcium current, intracellular calcium levels and cell survival by glucose deprivation and growth factors in hippocampal neurons. Brain Res 607: 275-285
6. Cronauer MV, Hittmair A, Eder IE, Hobisch A, Culig Z, Ramoner R, Zhang J, Bartsch, G. Reissigl A, Radmayr C, Thurnher M and Klocker H (1997a) Basic fibroblast growth factor levels in cancer cells and in sera of patients suffering from proliferative disorders of the prostate. Prostate 31: 223-233
7. Cronauer MV, Eder IE, Hittmair A, Sierek G, Hobisch A, Culig Z, Thurnher M, Bartsch G and Klocker H (1997b) A reliable system for the culture of human prostalic cells. In Vitro Cell Dev Biol Anim 33: 742-744
8. Culig Z, Hobisch A, Herold M, Hittmair A, Thurnher M, Eder IE, Cronauer MV, Rieser C, Ramoner R, Bartsch G, Klocker H and Konwalinka G (1998) Interleukin-1β mediates the modulatory effects of monocytes on LNCaP human prostate cancer cells. Br J Cancer 78: 1004-1011
9. Eder IE, Stenzl A, Hobisch A, Cronauer MV, Bartsch G and Klocker H (1997) Expression of transforming growth factors beta-1, beta 2 and beta 3 in human bladder carcinomas. Br J Cancer 75: 1753-1760
10. Froesch BA, Takayama S and Reed JC (1998) BAG-1L protein enhances androgen receptor function. J Biol Chem 273: 11660-11666
11. Gleave ME, Hsieh JT, Wu HC, von Eschenbach AC and Chung LWK (1992) Serum prostate specific antigen levels in mice bearing human prostate LNCaP tumors are determined by tumor volume and endocrine and growth factors. Cancer Res 52: 1598-1605
12. Gong Y, Blok LJ, Perry JE, Lindzey JK and Tindall DJ (1995) Calcium regulation of androgen receptor expression in the human prostate cancer cell line LNCaP. Endocrinology 136: 2172-2178
13. Grant ES, Batchelor KW and Habib FK (1996) Androgen independence of primary epithelial cultures of the prostate is associated with a down-regulation of androgen receptor gene expression. Prostate 29: 339-349
14. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260: 3440-3450
15. Hentlu P and Vihko P (1993) Growth factor regulation of gene expression in the human prostatic carcinoma cell line LNCaP. Cancer Res 53: 1051-1058
16. Hobisch A, Culig Z, Radmayr C, Bartsch G, Klocker H and Hittmair A (1995) Distant metastases from prostatic carcinoma express androgen receptor protein. Cancer Res 55: 3068-3072
17. Hobisch A, Culig Z, Radmayr C, Bartsch G, Klocker H and Hittmair A (1996) Androgen receptor status of lymph node metastases from prostate cancer. Prostate 28: 129-135
18. Hrzenjak M and Shain SA (1997) Fibroblast growth factor-2 and TPA enhance prostate cancer cell proliferation and activate members of the ras and PKC signal transduction pathways. Recept Signal Tranduct 7: 207-219
19. Hurley MM, Marcello K, Abreu C and Kessler M (1996) Signal transduction by basic fibroblast growth factor in rat osteoblastic Pyla cells. J Bone Mineral Res 11: 1256-1263
20. Ikonen T, Palvimo JJ, Kallio PJ, Reinikainen P and Jänne OA (1994) Stimulation of androgen-regulated transactivation by modulators of protein phosphorylation. Endocrinology 135: 1359-1366
21. Kallio PJ, Jänne OA and Palvimo JJ (1994) Agonists, but not antagonists, alter the conformation of the hormone-binding domain of androgen receptor. Endocrinology 134: 998-1001
22. Krongrad A, Wilson CM, Wilson JD, Allman DR and McPhaul MJ (1991) Androgen increases androgen receptor protein while decreasing receptor mRNA in LNCaP cells. Mol Cell Endocrinol 76: 79-88
23. 2+ content. J Mol Cell Cardiol 29: 2687-2698
24. Meyer GE, Yu E, Siegal JA, Petteway JC, Blumenstein BA and Brawer MK (1995) Serum basic fibroblast growth factor in men with and without prostate carcinoma. Cancer 76: 2304-2311
25. Milasincic DJ, Calera MR, Farmer SR and Pilch PF (1996) Stimulation of C2C12 myoblasl growth by basic fibroblast growth factor and insulin-like growth factor 1 occur via mitogen-activated protein kinase-dependent and -independent pathways. Mol Cell Biol 16: 5964-5973
26. Mizokami A, Saiga H, Matsui T, Mita T and Sugita A (1992) Regulation of androgen receptor by androgen and epidermal growth factor in a human proslatic cancer cell line, LNCaP. Endocrinol Jpn 39: 235-243
27. Mizokami A, Yeh SY and Chang C (1994) Identification of 3′5′-cyclic adenosine monophosphate response element and other cis-acting elements in the human androgen receptor gene promoter. Mol Endocrinol 8: 77-88
28. Nakamoto T, Chang CS, Li AK and Chodak GW (1992) Basic fibroblast growth factor in human prostate cancer cells. Cancer Res 52: 571-577
29. Peehl DM and Stamey TA (1986) Serum-free growth of adult human prostatic epithelial cells. In Vitro Cell Dev Biol 22: 82-90
30. Peterziel H, Culig Z, Stober J, Hobisch A, Radmayr C, Bartsch G, Klocker H and Cato AC (1995) Mutant androgen receptors in prostatic tumors distinguish between amino-acid-sequence requirements for transactivation and ligand binding. Int J Cancer 63: 544-550
31. Raffioni S and Bradshaw RA (1992) Activation of phosphalidylinositol 3-kinase by epidermal growth factor, basic fibroblast growth factor, and nerve growth factor in PC12 pheocromocytoma cells. Proc Natl Acad Sci USA 89: 9121-9125
32. Russell PJ, Bennett S, Joshua A, Yu Y, Downing SR, Hill MA, Kingsley EA, Mason RS and Berry J (1999) Elevated expression of FGF-2 does not cause prostate cancer progression in I.NCaP cells. Prostate 40: 1-13
33. Sa G and Fox PL (1994) Basic fibroblast growth factor-stimulated endothelial cell movement is mediated by a pertussis toxin-sensitive pathway regulating phospholipase A2 activity. J Biol Chem 269: 3219-3225
34. Shain SA, Saric T, Ke LD, Nannen D and Yoas S (1996) Endogenous fibroblast growth factor-1 or fibroblast growth factor-2 modulate prostate cancer cell proliferation. Cell Growth Diff 7: 573-586
35. Sherwood E, Lee C and Kozlowski JM (1992) Basic fibroblast growth factor: a potential mediator of stromal growth in the human prostate. Endocrinology 130: 2955-2963
36. Story MT, Livingston B, Baeten L, Schwartz SJ, Jacobs SC, Begun FP and Lawson RK (1989) Cultured human prostate-derived fibroblasts produce a factor that stimulates their growth with properties indistinguishable from basic fibroblast growth factor. Prostate 15: 355-365
37. Suzuki A, Shinoda J, Kanda S, Oiso Y and Kozawa O (1996) Basic fibroblast growth factor stimulates phosphatidylcholine-hydrolyzing phospholipase D in osteoblast-like cells. J Cell Biochem 63: 491-499
38. Tilley WD, Wilson CM, Marcelli M and McPhaul MJ (1990) Androgen receptor gene expression in human prostate carcinoma cell lines. Cancer Res 50: 5382-5386
39. 2+ signaling induced by activation of the epidermal growth factor and nerve growth factor receptors. J Biol Chem 271: 30505-30509
40. Van der Kwast TH, Schalken J, Ruizeveld de Winter JA, van Vroonhoven CCJ, Mulder E, Boersma W and Trapman J (1991) Androgen receptors in endocrine-therapy-resistant human prostate cancer. Int J Cancer 48: 189-193
41. Veldscholte J, Ris-Stalpers C, Kuiper GGJM, Jenster G, Berrevoets C, Claassen E, van Rooij HCJ, Trapman J and Brinkmann AO (1990) A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens. Biochem Biophys Res Commun 17: 534-540
42. Wasilenko WJ, Cooper J, Palad AJ, Somers KD, Blackmore PF, Rhim JS, Wright GLJ and Schellhammer PF (1997) Calcium signaling in prostate cancer cells: evidence for multiple receptors and enhanced sensitivity to bombesin/GRP. Prostate 30: 167-173
43. Wiren KM, Zhang X, Chang C, Keenan E and Orwoll ES (1997) Transcriptional up-regulation of the human androgen receptor by androgen in bone cells. Endocrinology 138: 2291-2300
44. Yeh S and Chang C (1996) Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells. Proc Natl Acad Sci USA 93: 5517-5521
45. Young C-F, Murtha PE, Andrews PE, Lindzey JK and Tindall DJ (1994) Antagonism of androgen action in prostate tumor cells by retinoic acid. Prostate 25: 39-45
46. Zhou ZX, Lane MV, Kemppainen JA, French FS and Wilson EM (1995) Specificity of ligand-depcndent androgen receptor stabilization: receptor domain interactions influence ligand dissociation and receptor stability. Mol Endocrinol 9: 208-218